Skip to main content
European Consortium of Lipodystrophies (ECLip)
  • Home
  • Goals
  • Lipodystrophies
    • Classification
  • Groups
    • Austria
      • Foisner Lab
      • Scherer Lab
    • Belgium
      • Unité de Recherche en Biologie Cellulaire (Namur)
      • Cell Systems and Imaging (Ghent)
      • Universitair Ziekenhuis Antwerpen (Antwerp)
    • Bulgaria
    • Cuba
    • Cyprus
    • Egypt
    • France
      • Paris-Saint-Antoine PRISIS-Inserm UMR_S938 team
      • Genetics, Pathophysiology and Therapeutic Approach
      • Paediatric Endocrinology Unit (Paris)
      • INSERM UMR_S 1087 (Nantes)
      • Lille Group (Lille)
      • ​Premature Aging Syndromes & Lipodystrophies​
      • Pediatric Endocrinology and Diabetology (Paris)
    • Germany
      • Hoffmann Group (Halle)
      • Clinic for Transplantation Medicine (Münster)
      • Dep. of Pediatrics and Adolescent Medicine (Ulm)
      • IFB Lipodystrophy Centre (Leipzig)
    • Greece
      • ​Paediatric HIV Referral Unit (Athens)
      • Unit of Reproductive Endocrinology (Thessaloniki)
    • Israel
    • Italy
      • Laminopathy Research Laboratory (Bologna)
      • Human Lipodystrophies (Bologna)
      • Obesity Center-Endocrinology Unit (Pisa)
      • Laboratory of Medical Genetics (Roma)
      • Gene Expression - Microarrays Laboratory (Roma)
    • Lithuania
    • Netherlands
      • Maastricht University Hospital
      • Leiden University Medical Center
      • Amsterdam UMC
    • Norway
    • Oman
    • Peru
    • Poland
    • Portugal
      • Porto University
      • Grupo de Estudo das Lipodistrofias do CMIN (Porto)
    • Russia
      • ERC
      • RLSG
    • Serbia
    • Slovenia
    • Spain
      • UETeM - Molecular Pathology Group (Santiago)
      • Stem Cell Laboratory (Vizcaya)
      • Rheumatology Division Proteomics Group (A Coruña)
      • Department of Medical Sciences (Ciudad Real)
      • Adipobiology Group (Córdoba)
      • Uniovi (Oviedo)
      • Dep. Biochemistry & Molecular Biology (Barcelona)
      • Clinical Genetics and Rare Diseases (Murcia)
      • Fundación Galega de Medicina Xenómica (Santiago)
      • Complement system IdiPAZ (Madrid)
    • Sweden
      • Eriksson Group
      • MU Endocrinology and Cardio Metabolic Unit
    • Switzerland
    • Taiwan
    • Turkey
    • United Arab Emirates
    • United Kingdom
      • Nat. Severe Insulin Resistance Service (Cambridge)
      • Centre for Cardiovascular Science (Edinburgh)
      • University of Aberdeen
    • USA
      • NIDDK (Maryland)
      • University of Michigan
  • Information
    • Advocacy groups
    • Clinical centres
    • Executive board
      • Disclosure
    • Registry
  • News
  • Meetings
    • 2015 World Lipodystrophy Day
    • 2016 ECLip Annual Meeting
    • 2017 ECLip Annual Meeting
    • 2018 ECLip Annual Meeting
    • 2019 ECLip Annual Meeting
      • Gallery
    • 2020 ECLip Annual Meeting
    • 2022 ECLip Annual Meeting
    • 2023 ECLip Annual Meeting
    • 2025 ECLip Annual Meeting
    • 2026 ECLip Annual Meeting
  • Publications
    • Lipodystrophy papers of the month
    • Collaborative ECLip Publications
  • Contact
  • Ask the experts

Recent Posts

  • ECLip consensus paper selected as December 2026 Editors' Choice by Journal of Internal Medicine
    19 Nov, 2026
  • Digital patient seminar - Ulm University Hospital and NetLip
    27 Mar, 2024
  • X ECLip Annual Meeting 2025: see you in Paris!
    2 Oct, 2023
  • IX ECLip Annual Meeting 2023: a success, again!
    2 Oct, 2023
  • Prof. David Araújo-Vilar, re-elected President of the European Consortium of Lipodystrophies (ECLip)
    30 Sep, 2023
  • Registration and abstract submission are open for the 4th International Meeting on Laminopathies
    18 Jan, 2023
  • 4th International Meeting on Laminopathies 2023 (Madrid, 9-12 May)
    14 Dec, 2022

ECLip consensus paper selected as December 2026 Editors' Choice by Journal of Internal Medicine

November 19, 2026 at 2:01 am

ECLip consensus paper selected as December 2026 Editors' Choice by Journal of Internal Medicine

The Journal of Internal Medicine has selected the European Consortium for Lipodystrophies (ECLip) consensus paper on the definition and classification of lipodystrophy as its Editors' Choice for December 2026.

The publication, “European Consortium for Lipodystrophies consensus definition and classification framework for monogenic lipodystrophy”, is the result of an international collaborative effort involving 26 clinicians and researchers from 14 countries.

The consensus was developed through a series of working group discussions and revisions between March 2024 and December 2025, resulting in a definition unanimously approved by the participating specialists.

Establishing a common definition of lipodystrophy

The paper defines lipodystrophy as deficient development and/or inadequate maintenance of adipose tissue that cannot be explained by nutritional deprivation or systemic catabolic conditions.

It emphasizes the need to consider both anatomical changes in adipose tissue and evidence of adipose tissue dysfunction or pathology. This distinction is particularly relevant in differentiating lipodystrophy from physiological leanness and other conditions associated with reduced adipose tissue mass.

The proposed definition applies to lipodystrophy in general, including genetic and acquired forms.

A proposed framework for monogenic lipodystrophy

The second component of the paper introduces a hierarchical system for assessing the strength of evidence supporting gene–disease associations in monogenic lipodystrophy.

The framework prioritizes human clinical and genetic evidence, complemented by experimental findings, and distinguishes between confirmed, probable, possible, unsupported and refuted associations.

This system is intended to support more consistent classification of established and emerging monogenic lipodystrophy syndromes, while allowing reassessment as additional evidence becomes available.

International collaboration and editorial recognition

The article brings together specialists in adult and pediatric endocrinology, clinical genetics and lipodystrophy research. 

The selection as December Editors' Choice acknowledges the article through the journal's editorial selection programme. 

ECLip thanks all contributing authors for their work in developing this consensus.

Reference: Semple RK et al. European Consortium for Lipodystrophies consensus definition and classification framework for monogenic lipodystrophy. Journal of Internal Medicine. 2026;300(6):725–742.

Full article (Open Access): https://doi.org/10.1111/joim.70157

2019 European Consortium of Lipodystrophies (ECLip)